Amarin Corporation Return on Assets:
-73.18% for Dec. 31, 2012Amarin Corporation Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -73.18% |
| Sept. 30, 2012 | -71.90% |
| June 30, 2012 | -14.86% |
| March 31, 2012 | -111.6% |
| Dec. 31, 2011 | -61.53% |
| Sept. 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| Dec. 31, 2010 | |
| Sept. 30, 2010 |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
AMRN Return on Assets Benchmarks
| Companies | |
|---|---|
| Omthera Pharmaceuticals | |
| Achillion Pharmaceuticals | -47.81% |
| Alexza Pharmaceuticals | -58.58% |
AMRN Return on Assets Rankings
| Overall |
41st percentile 4679 of 8002 |
| Sector |
30th percentile 476 of 684 in Healthcare |
| Industry |
29th percentile 48 of 68 in Drug Manufacturers - Specialty & Generic |
AMRN Return on Assets Range, Past 5 Years
| Minimum | -111.6% | Mar 2012 |
| Maximum | -14.86% | Jun 2012 |
| Average | -65.58% |
